Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background/objectives Reduced consumption of trans-fatty acids (TFA) is desirable to lower coronary heart disease (CHD) risk. In practice, partially hydrogenated vegetable oils (PHVO) that contain both TFAs and other fatty acids are the unit of replacement and could be replaced with diverse alternative fats and oils. We performed quantitative estimates of CHD effects if a person's PHVO consumption were to be replaced with alternative fats and oils based on (1) randomized dietary trials and (2) prospective observational studies.Subjects/methods We performed meta-analyses of (1) the effects of TFAs on blood lipids and lipoproteins in controlled dietary trials and (2) associations of habitual TFA consumption with CHD outcomes in prospective cohort studies. On the basis of these results and corresponding findings for saturated fatty acids (SFA), cis-monounsaturated fatty acids (MUFA) and cis-polyunsaturated fatty acids (PUFA), we calculated the effects on CHD risk for replacing 7.5% of energy from three different PHVO formulations (containing 20, 35 or 45% TFAs) with butter, lard, palm or vegetable oils.Results In controlled trials, each 1% energy replacement of TFAs with SFAs, MUFAs or PUFAs, respectively, decreased the total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) ratio by 0.31, 0.54 and 0.67; the apolipoprotein (Apo)-B/ApoAI ratio by 0.007, 0.010 and 0.011; and lipoprotein (Lp)(a) by 3.76, 1.39 and 1.11 mg/l (P<0.05 for each). We also included possible effects on C-reactive protein (CRP) of TFAs vs other fats from one trial. On the basis of these risk factor changes in controlled trials, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: -2.7% (butter) to -9.9% (canola)); 35% TFA PHVO (-11.9% (butter) to -16.0% (canola)); or 45% TFA PHVO (-17.6% (butter) to -19.8% (canola)). In prospective cohort studies, each 2% energy replacement of TFAs with SFAs, MUFAs or PUFAs would lower CHD risk by 17% (95% confidence interval (CI)=7-25%), 21% (95% CI=12-30%) or 24% (95% CI=15-33%), respectively. On the basis of these associations in observational studies, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: +0.5% (butter) to -21.8% (soybean)); 35% TFA PHVO (-14.4% (butter) to -33.4% (soybean)); or 45% TFA PHVO (-22.4% (butter) to -39.6% (soybean)). The demonstrated effects on TC/HDL-C, ApoB/ApoAI, Lp(a), and CRP in randomized feeding trials together accounted for approximately 65-80% and approximately 50% of the estimated risk reduction for replacing PHVO with animal fats and vegetable oils, respectively, that would be calculated from prospective cohort studies.Conclusions Effects on CHD risk of removing PHVO from a person's diet vary depending on the TFA content of the PHVO and the fatty acid composition of the replacement fat or oil, with direct implications for reformulation of individual food products. Accounting for the summed effects of TFAs on multiple CHD risk factors provides more accurate estimates of potential risk reduction than considering each risk factor in isolation, and approaches the estimated risk reduction derived from prospective cohort studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.283”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [283]
In the citing paper
“Substituting calories from mono- or poly-unsaturated fat with trans fatty acids increases LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a), and lowers plasma high-density lipoprotein cholesterol and apolipoprotein A1 levels (44).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [44]
In the citing paper
“Weight loss has a beneficial effect on lipids and lipoproteins.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [385]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Summary estimates were obtained using random effects meta-analysis weighted by the inverse variance log RRs of the individual studies (DerSimonian and Laird, 1986).”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · cited 2×
“For an estimated 1.2 mg/l higher CRP, the RR was 1.58 (95% CI¼1.48–1.68) (Danesh et al., 2004).”
MethodInfluentialMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“The effects on blood lipid concentrations of isocaloric changes between consumption of SFAs, MUFAs and PUFAs were calculated from a prior meta-analysis of randomized controlled dietary trials (Mensink et al., 2003).”
Method(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 3×
“For a 1.33 decrease in the TC/HDL-C ratio, the relative risk (RR) of CHD (weighted across age groups) was 0.61 (95% confidence interval (CI)¼0.55–0.69) after correction for regression dilution bias (Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 11×
“…controlled feeding trials and of associations of habitual TFA consumption with clinical endpoints in prospective cohort studies, the estimated effects on CHD risk of replacing TFAs with equivalent calories from carbohydrate or cis-unsaturated fats has been estimated (Mozaffarian et al., 2006).”
BackgroundResultInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 2×
“For example, the use of objective biomarkers of TFA consumption (for example, erythrocyte membrane levels) (Sun et al., 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundLipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938 · cited 2×
“…TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP if 7.5% of energy from PHVO were replaced with alternative fats and oils were calculated using established relationships between these risk factors and the incidence of CHD (Danesh et al., 2000, 2004; Yusuf et al., 2004; Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluential
Cited by
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Self-citationEckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Metadata
- Authors
- Mozaffarian, D., & Clarke, R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Oxford (GB)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S22-S33
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2053223480
- Cited by
- 410
- References
- 44
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 19 · 2023: 16 · 2022: 13 · 2021: 27 · 2020: 30 · 2019: 19 · 2018: 16 · 2017: 18 · 2016: 27 · 2015: 33 · 2014: 35 · 2013: 35 · 2012: 42
- FWCI
- 34.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonterra Co-Operative Group
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, partially hydrogenated vegetable oils, coronary heart disease risk, fat replacement, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, serum lipids, lipoproteins, apolipoprotein B/apolipoprotein A-I ratio, lipoprotein(a), C-reactive protein, butter, lard, palm oil, vegetable oils, canola
- MeSH terms
- Animals, C-Reactive Protein, Cardiovascular Diseases, Cholesterol, Coronary Disease, Dietary Fats, Fatty Acids, Humans, Hydrogenation, Lipids, Plant Oils, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. https://app.cochat.ai/papers/10.1038/sj.ejcn.1602976
- The paper
- Mozaffarian, D., & Clarke, R. (2009). Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. European Journal of Clinical Nutrition. https://doi.org/10.1038/sj.ejcn.1602976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.